[1]
2026. Cost-effectiveness analysis of combined antidiabetic therapy for type 2 diabetes mellitus in a tertiary health institution in north-central Nigeria . Nigerian Journal of Pharmaceutical and Biomedical Research (NJPBR). 6, 1 (Apr. 2026), 184–195. DOI:https://doi.org/10.55639/fmv5fc67.